News

Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...
A genetically modified herpes simplex virus, called RP1, has now been shown to destroy advanced melanoma tumors, even when ...
The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...
University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically modifying HSV-1 and administering it to patients with treatment-resistant, ...
A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...
One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.
Conjunctivitis, commonly known as pink eye, is a contagious infection causing redness, itching, and discharge. Viral, ...
Modified Herpes Virus as a Weapon Against Skin Cancer? A new study suggests it might work—even for metastases deep within the body that have been difficult to target. This combination therapy could ...
IT IS now widely accepted that most adults are latently infected with the virus of herpes simplex.1 , 2 This latent infection may be activated by a large number of apparently dissimilar stimuli suc ...
CG Oncology, Inc. (NASDAQ:CGON) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 17, ...